AKUMS
Invest with MTF
Invest Now
Invest in Akums Drugs & Pharmaceuticals with 3.23X leverage
Performance
- Low
- ₹418
- High
- ₹429
- 52 Week Low
- ₹405
- 52 Week High
- ₹678
- Open Price₹418
- Previous Close₹422
- Volume136,417
Investment Returns
- Over 1 Month -6.04%
- Over 3 Month -7.85%
- Over 6 Month -25.05%
- Over 1 Year -31.77%
Smart Investing Starts Here Start SIP with Akums Drugs & Pharmaceuticals for Steady Growth!
Akums Drugs & Pharmaceuticals Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 21.1
- PEG Ratio
- 1.5
- Market Cap Cr
- 6,704
- P/B Ratio
- Average True Range
- 11.33
- EPS
- 19.54
- Dividend Yield
- 0
- MACD Signal
- -8.25
- RSI
- 45.74
- MFI
- 40.25
Akums Drugs & Pharmaceuticals Financials
Akums Drugs & Pharmaceuticals Technicals
EMA & SMA
Current Price
₹425.95
+
4.35
(1.03%)
- Bearish Moving Average 10
- Bullish Moving Average 6
- 20 Day
- ₹427.63
- 50 Day
- ₹442.66
- 100 Day
- ₹465.99
- 200 Day
- ₹522.25
Resistance and Support
424.15
- R3 440.80
- R2 434.65
- R1 430.30
- S1 419.80
- S2 413.65
- S3 409.30
Akums Drugs & Pharmaceuticals Corporate Actions - Bonus, Splits, Dividends
| Date | Purpose | Remarks |
|---|---|---|
| 2025-11-13 | Quarterly Results | |
| 2025-08-08 | Quarterly Results | |
| 2025-05-26 | Audited Results | |
| 2025-02-06 | Quarterly Results | |
| 2024-11-09 | Quarterly Results |
Akums Drugs & Pharmaceuticals F&O
About Akums Drugs & Pharmaceuticals
- NSE Symbol
- AKUMS
- BSE Symbol
- 544222
- Managing Director
- Mr. Sanjeev Jain
- ISIN
- INE09XN01023
Similar Stocks to Akums Drugs & Pharmaceuticals
Akums Drugs & Pharmaceuticals FAQs
Akums Drugs & Pharmaceuticals share price is ₹425 As on 10 December, 2025 | 17:52
The Market Cap of Akums Drugs & Pharmaceuticals is ₹6704.2 Cr As on 10 December, 2025 | 17:52
The P/E ratio of Akums Drugs & Pharmaceuticals is 21.1 As on 10 December, 2025 | 17:52
The PB ratio of Akums Drugs & Pharmaceuticals is 2.2 As on 10 December, 2025 | 17:52
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.